Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.